Parison Amy
SEC CIK 2063082 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EDIT | Editas Medicine, Inc. | SVP, CFO | 13.8K | — | $10.0K | 8 | 2025-06-03 | 2026-09-03 |
Most active insiders at EDIT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Neill Gilmore Neil | CEO, Dir | — | $80.0K |
| 2 | Burkly Linda | EVP, CSO | — | $20.3K |
| 3 | Parison Amy | SVP, CFO | — | $6,327 |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-04 16:25 | 2026-09-03 | EDIT | Editas Medicine, Inc. | Parison Amy | SVP, CFO | S - Sale | $3.04 | -453 | 13.8K | -3% | -$1,376 |
| T | 2026-08-05 16:07 | 2026-08-03 | EDIT | Editas Medicine, Inc. | Parison Amy | SVP, CFO | S - Sale | $2.58 | -678 | 14.3K | -5% | -$1,749 |
| T | 2026-06-05 16:33 | 2026-06-03 | EDIT | Editas Medicine, Inc. | Parison Amy | SVP, CFO | S - Sale | $2.70 | -464 | 15.0K | -3% | -$1,253 |
| 2026-03-04 | 2026-03-03 | EDIT | Editas Medicine, Inc. | Parison Amy | SVP, CFO | S - Sale | $2.02 | -474 | 15.4K | -3% | -$957.48 | |
| 2025-12-04 | 2025-12-03 | EDIT | Editas Medicine, Inc. | Parison Amy | SVP, CFO | S - Sale | $2.15 | -461 | 15.9K | -3% | -$991.15 | |
| 2025-09-04 | 2025-09-03 | EDIT | Editas Medicine, Inc. | Parison Amy | SVP, CFO | S - Sale | $2.60 | -458 | 16.4K | -3% | -$1,191 | |
| 2025-08-08 | 2025-08-07 | EDIT | Editas Medicine, Inc. | Parison Amy | SVP, CFO | S - Sale | $2.58 | -679 | 16.8K | -4% | -$1,752 | |
| 2025-06-04 | 2025-06-03 | EDIT | Editas Medicine, Inc. | Parison Amy | SVP, CFO | S - Sale | $1.72 | -446 | 17.5K | -2% | -$767.12 |
Purchase Sale Sale after option exercise All abbreviations